FTC Says Patent Infringement Suits Are Not Antitrust Proof
Takeda Pharmaceutical Co. Ltd. can't dodge antitrust counterclaims from generic drugmaker Zydus Pharmaceuticals (USA) Inc. simply by arguing that it is allowed to sue generics companies for patent infringement when they...To view the full article, register now.
Already a subscriber? Click here to view full article